Abstract
The crosstalk in the functional interplay of the neuroimmune system is essential to ensure homeostasis preservation and health. Alzheimer’s disease (AD) can be understood in the context of aging of this neuroimmune communication. AD has an important genderdependent component and is benefitted by lifestyle strategies such as physical exercise, enriched environments and nutrition. Recently, the functional and redox state of peripheral immune cells has been proposed as a useful tool for measuring the progression of AD. The present review summarizes the relevance of the disruption of crosstalk among neurons, glial cells, immune mediators and cells from the very beginning of the prodromal stages of AD, when early BPSD symptoms have already started but cognitive function still seems apparently normal. The study of the role of neuroimmune system and how its disruption contributes to the onset of disease may help in understanding its biological mechanisms and in finding behavioral parameters and immunological biomarkers for the prodromic phases. Here we present results of 3xTg-AD mice from pre-morbid to early-stages of AD and how early BPSD-like symptoms correlate with changes in the organometrics of thymus and spleen that are indirect indicators of the immunological status. These functional relationships between behavioral and peripheral system also revealed the existence of differences between biological and chronological ages (an advanced biological age) since the prodromal stages. Overall, the data available suggest that the crosstalk between behavior (nervous) and immune system plays an important role since prodromal stages of AD.
Keywords: Behavior, Peripheral immune system, neuroimmunoendocrine communication, Alzheimer’s disease, Age.
Current Pharmaceutical Design
Title:Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease
Volume: 20 Issue: 29
Author(s): Lydia Gimenez-Llort, Virginia Torres-Lista and Monica De la Fuente
Affiliation:
Keywords: Behavior, Peripheral immune system, neuroimmunoendocrine communication, Alzheimer’s disease, Age.
Abstract: The crosstalk in the functional interplay of the neuroimmune system is essential to ensure homeostasis preservation and health. Alzheimer’s disease (AD) can be understood in the context of aging of this neuroimmune communication. AD has an important genderdependent component and is benefitted by lifestyle strategies such as physical exercise, enriched environments and nutrition. Recently, the functional and redox state of peripheral immune cells has been proposed as a useful tool for measuring the progression of AD. The present review summarizes the relevance of the disruption of crosstalk among neurons, glial cells, immune mediators and cells from the very beginning of the prodromal stages of AD, when early BPSD symptoms have already started but cognitive function still seems apparently normal. The study of the role of neuroimmune system and how its disruption contributes to the onset of disease may help in understanding its biological mechanisms and in finding behavioral parameters and immunological biomarkers for the prodromic phases. Here we present results of 3xTg-AD mice from pre-morbid to early-stages of AD and how early BPSD-like symptoms correlate with changes in the organometrics of thymus and spleen that are indirect indicators of the immunological status. These functional relationships between behavioral and peripheral system also revealed the existence of differences between biological and chronological ages (an advanced biological age) since the prodromal stages. Overall, the data available suggest that the crosstalk between behavior (nervous) and immune system plays an important role since prodromal stages of AD.
Export Options
About this article
Cite this article as:
Gimenez-Llort Lydia, Torres-Lista Virginia and Fuente De la Monica, Crosstalk between Behavior and Immune System During the Prodromal Stages of Alzheimer`s Disease, Current Pharmaceutical Design 2014; 20 (29) . https://dx.doi.org/10.2174/1381612820666140130205500
DOI https://dx.doi.org/10.2174/1381612820666140130205500 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Protective Effects of Crocetin on Aβ<sub>1-42</sub>-Induced Toxicity in Ht22 Cells
CNS & Neurological Disorders - Drug Targets Chinese Medicinal Herbs as Source of Antioxidant Compounds – Where Tradition Meets the Future
Current Medicinal Chemistry Appraisal of AβPP Transgenic Mice as Models for Alzheimers Disease Amyloid Cascade
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Apathy Is not Associated with Performance in Brief Executive Tests in Patients with Mild Cognitive Impairment and Mild Alzheimers Disease
Current Alzheimer Research Patterns of Cognitive Decline and Rates of Conversion to Dementia in Patients with Degenerative and Vascular forms of MCI
Current Alzheimer Research Gender Differences in Response to Therapy for Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine Dry Age-Related Macular Degeneration: Recent Progress of Therapeutic approaches
Current Molecular Pharmacology Arundic Acid (ONO-2506) Ameliorates Delayed Ischemic Brain Damage by Preventing Astrocytic Overproduction of S100B
Current Drug Targets - CNS & Neurological Disorders Antimetastatic Potential of Quercetin Analogues with Improved Pharmacokinetic Profile: A Pharmacoinformatic Preliminary Study
Anti-Cancer Agents in Medicinal Chemistry Actigraphy for Assessing Light Effects on Sleep and Circadian Activity Rhythm in Alzheimer's Dementia: A Narrative Review
Current Alzheimer Research Early Intervention in Psychosis: Rationale, Results and Implications for Treatment of Adolescents at Risk
Adolescent Psychiatry Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimers Disease Pyramidal Neurons
Current Pharmaceutical Design Psychopathological Behaviour and Cognition in Morbid Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit
Current Neurovascular Research Statins May Prevent Atherosclerotic Disease in OSA Patients without Co-Morbidities?
Current Vascular Pharmacology Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
CNS & Neurological Disorders - Drug Targets Variability in Reward Responsivity and Obesity: Evidence from Brain Imaging Studies
Current Drug Abuse Reviews Regulation of Ion Channels, Cellular Carriers and Na(+)/K(+)/ATPase by Janus Kinase 3
Current Medicinal Chemistry Aluminum Induced Immunoexcitotoxicity in Neurodevelopmental and Neurodegenerative Disorders
Current Inorganic Chemistry (Discontinued) Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design